Login to Your Account



Financings Roundup

At-the-Market Financing Facility Secures ISCO $25M

By Catherine Shaffer


Tuesday, December 14, 2010
Aspire Capital Fund LLC agreed to purchase 333,333 shares of International Stem Cell Corp. (ISCO) at $1.50 per share, a 7 percent premium over Friday's closing price of $1.40. In addition, the agreement includes a financing facility that will allow Aspire to purchase up to a total of $25 million in equity capital over the next three years, at the discretion of ISCO.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription